Proximagen Neuroscience Plc (PRX.L) and Minster Pharmaceuticals PLC (MPM.L) announced that they have reached agreement on the terms of a recommended cash offer by Proximagen for the entire issued and to be issued share capital of Minster.
As per the terms of the Offer, Minster Shareholders will receive 6.0 pence in cash for each Minster Share held by them, valuing the entire issued and to be issued share capital of Minster at about £4.3 million.
The Offer represents a premium of about 45.45% to the Closing Price of 4.13 pence per Minster Share on 31 December 2009, being the last dealing day prior to this announcement.
The Minster Directors unanimously intend to recommend that all Minster Shareholders accept the Offer, as those Minster Directors who hold Minster Shares have irrevocably undertaken to do in respect of each of their own respective beneficial holdings of Minster Shares amounting, in aggregate, to 14.43 million Minster Shares, representing about 24.50% of the existing issued share capital of Minster.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.